SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-21-009398
Filing Date
2021-04-21
Accepted
2021-04-21 17:55:11
Documents
1
Period of Report
2021-04-16

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 7458
  Complete submission text file 0001493152-21-009398.txt   9049
Mailing Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 856-848-8698
MyMD Pharmaceuticals, Inc. (Issuer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences

Mailing Address AKERS BIOSCIENCES, INC. 201 GROVE ROAD THOROFARE NJ 08086
Business Address
Schreiber Christopher C (Reporting) CIK: 0001750076 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36268 | Film No.: 21842644